Free Newsletter
Software maker breaches bio fortress
A maker of security software for the management of confidential documents earned membership into an exclusive life sciences club--the Massachusetts Biotechnology Council. Brainloop based its appeal to the bio-science organization on the match-up between its secure online work space for outlicensing and collaboration and biotech discovery and development efforts. Release
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
